Literature DB >> 7736541

Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3.

S Kanda1, H Takeyama, Y Kikumoto, S L Morrison, D L Morton, R F Irie.   

Abstract

Previously we developed a murine monoclonal anti-idiotype (anti-id) antibody (4C10) that mimics the melanoma-associated ganglioside antigen GM3, that is, it carries the internal image of GM3. 4C10 was made against the human monoclonal antibody (HuMAb) L612, which reacts with several types of human cancer cells, including melanoma and breast cancer. To reduce mouse components of 4C10, the constant region was replaced by a human constant domain to form the murine/human chimeric anti-id antibody TVE-1. In the present study, we sought to determine which chain (VH or VL) of the anti-id is responsible for the antigenicity of GM3. The TVE-1 VH and VL expression vectors were simultaneously transfected with either the VH or VL expression vector of a murine-human chimeric IgG antidansyl haptenic antibody, resulting in the construction of three different combinations of VH and VL chimeric antibodies. These IgG molecules were produced from the transfectomas, and their reactivity to HuMAb L612 was tested. Neither of the IgG proteins that had cross-combined the VH-VL pair showed positive results, suggesting that both heavy and light chains are required to express the antigenicity. The in vivo antigenicity of this chimeric anti-id was confirmed by skin tests in melanoma patients receiving active specific immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7736541     DOI: 10.1007/bf02789216

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  10 in total

1.  Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen.

Authors:  C Bruck; M S Co; M Slaoui; G N Gaulton; T Smith; B N Fields; J I Mullins; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

Review 3.  Epitope mimicry by anti-idiotype sequences in reverse orientation.

Authors:  D W Metzger; C W Naeve; V H Van Cleave
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

4.  Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.

Authors:  S Yamamoto; T Yamamoto; R E Saxton; D S Hoon; R F Irie
Journal:  J Natl Cancer Inst       Date:  1990-11-21       Impact factor: 13.506

5.  A search for site-filling ligands in the Mcg Bence-Jones dimer: crystal binding studies of fluorescent compounds.

Authors:  A B Edmundson; K R Ely; J N Herron
Journal:  Mol Immunol       Date:  1984-07       Impact factor: 4.407

6.  Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside.

Authors:  A Hastings; S L Morrison; S Kanda; R E Saxton; R F Irie
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

7.  Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects--incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme.

Authors:  R J Thompson; A P Jackson; N Langlois
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

8.  Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.

Authors:  D S Hoon; Y Wang; L Sze; H Kanda; T Watanabe; S L Morrison; D L Morton; R F Irie
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

9.  Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

Authors:  D L Morton; L J Foshag; D S Hoon; J A Nizze; E Famatiga; L A Wanek; C Chang; D G Davtyan; R K Gupta; R Elashoff
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

10.  The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.

Authors:  S M Canfield; S L Morrison
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.